128 related articles for article (PubMed ID: 8545542)
1. Recent advances in benzodiazepine receptor (BZR) binding studies.
Gupta SP
Prog Drug Res; 1995; 45():67-106. PubMed ID: 8545542
[No Abstract] [Full Text] [Related]
2. Endogenous ligands of the benzodiazepine receptor.
Haefely W
Pharmacopsychiatry; 1988 Jan; 21(1):43-6. PubMed ID: 2834760
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of novel 3-substituted beta-carbolines as benzodiazepine receptor ligands: probing the benzodiazepine receptor pharmacophore.
Allen MS; Hagen TJ; Trudell ML; Codding PW; Skolnick P; Cook JM
J Med Chem; 1988 Sep; 31(9):1854-61. PubMed ID: 2842507
[TBL] [Abstract][Full Text] [Related]
4. Comparative quantitative structure-activity relationship studies (QSAR) on non-benzodiazepine compounds binding to benzodiazepine receptor (BzR).
Hadjipavlou-Litina D; Garg R; Hansch C
Chem Rev; 2004 Sep; 104(9):3751-94. PubMed ID: 15352779
[No Abstract] [Full Text] [Related]
5. Quantitative structure-activity relationship studies of a series of non-benzodiazepine structural ligands binding to benzodiazepine receptor.
Xia B; Ma W; Zheng B; Zhang X; Fan B
Eur J Med Chem; 2008 Jul; 43(7):1489-98. PubMed ID: 17964693
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationship studies at the benzodiazepine receptor (BZR): a comparison of the substitutent effects of pyrazoloquinolinone analogs.
Fryer RI; Zhang P; Rios R; Gu ZQ; Basile AS; Skolnick P
J Med Chem; 1993 May; 36(11):1669-73. PubMed ID: 8388472
[TBL] [Abstract][Full Text] [Related]
7. Substituted 3-(2-benzoxazyl)-benzimidazol-2-(1H)-ones: a new class of GABA(A) brain receptor ligands.
DeSimone RW; Blum CA
Bioorg Med Chem Lett; 2000 Dec; 10(24):2723-6. PubMed ID: 11133077
[TBL] [Abstract][Full Text] [Related]
8. Novel N-(arylalkyl)indol-3-ylglyoxylylamides targeted as ligands of the benzodiazepine receptor: synthesis, biological evaluation, and molecular modeling analysis of the structure-activity relationships.
Primofiore G; Settimo FD; Taliani S; Marini AM; Novellino E; Greco G; Lavecchia A; Besnard F; Trincavelli L; Costa B; Martini C
J Med Chem; 2001 Jul; 44(14):2286-97. PubMed ID: 11428922
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationship studies of novel pyrazolo[1,5-c][1,3]benzoxazines: synthesis and benzodiazepine receptor affinity.
Varano F; Catarzi D; Colotta V; Cecchi L; Filacchioni G; Galli A; Costagli C
Arch Pharm (Weinheim); 1996 Dec; 329(12):529-34. PubMed ID: 9038420
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of some 2-aryl-1,2,4-triazolo[1,5-c][1,3]benzoxazin-5-ones as tools to define the essential pharmacophoric descriptors of a benzodiazepine receptor ligand.
Catarzi D; Cecchi L; Colotta V; Filacchioni G; Varano F; Martini C; Giousti L; Lucacchini A
J Med Chem; 1995 Jun; 38(12):2196-201. PubMed ID: 7783151
[TBL] [Abstract][Full Text] [Related]
11. From the pharmacophore to the homology model of the benzodiazepine receptor: the indolyglyoxylamides affair.
Cosimelli B; Cosconati S; Marinelli L; Novellino E; Greco G
Curr Top Med Chem; 2012; 12(4):321-32. PubMed ID: 22204482
[TBL] [Abstract][Full Text] [Related]
12. Chronic exposure to benzodiazepine receptor ligands uncouples the gamma-aminobutyric acid type A receptor in WSS-1 cells.
Wong G; Lyon T; Skolnick P
Mol Pharmacol; 1994 Dec; 46(6):1056-62. PubMed ID: 7808424
[TBL] [Abstract][Full Text] [Related]
13. Pharmacophore/receptor models for GABA(A)/BzR subtypes (alpha1beta3gamma2, alpha5beta3gamma2, and alpha6beta3gamma2) via a comprehensive ligand-mapping approach.
Huang Q; He X; Ma C; Liu R; Yu S; Dayer CA; Wenger GR; McKernan R; Cook JM
J Med Chem; 2000 Jan; 43(1):71-95. PubMed ID: 10633039
[TBL] [Abstract][Full Text] [Related]
14. Benzodiazepine receptor binding activity of 9-(1-phenylethyl)purines.
Kelley JL; McLean EW; Ferris RM; Howard JL
J Med Chem; 1990 Jul; 33(7):1910-4. PubMed ID: 2163452
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and BZR affinity of pyrazolo[1,5-a]pyrimidine derivatives. Part 1: study of the structural features for BZR recognition.
Selleri S; Bruni F; Costagli C; Costanzo A; Guerrini G; Ciciani G; Costa B; Martini C
Bioorg Med Chem; 1999 Dec; 7(12):2705-11. PubMed ID: 10658575
[TBL] [Abstract][Full Text] [Related]
16. The rational design and synthesis of haptens having specific activity as full agonists or full antagonists at the benzodiazepine receptor.
Fryer RI; Gu ZQ
Life Sci; 1990; 47(10):833-40. PubMed ID: 2170789
[TBL] [Abstract][Full Text] [Related]
17. Tricyclic heteroaromatic systems. 1,2,4-triazolo[4,3-a]quinoxalines and 1,2,4-Triazino[4,3-a]quinoxalines: synthesis and central benzodiazepine receptor activity.
Colotta V; Catarzi D; Varano F; Cecchi L; Filacchioni G; Galli A; Costagli C
Arch Pharm (Weinheim); 1997 Dec; 330(12):387-91. PubMed ID: 9474898
[TBL] [Abstract][Full Text] [Related]
18. Binding profiles and physical dependence liabilities of selected benzodiazepine receptor ligands.
Richards JG; Martin JR
Brain Res Bull; 1998; 45(4):381-7. PubMed ID: 9527012
[TBL] [Abstract][Full Text] [Related]
19. Benzodiazepine receptor affinity and interaction of some N-(indol-3-ylglyoxylyl)amine derivatives.
Bianucci AM; Da Settimo A; Da Settimo F; Primofiore G; Martini C; Giannaccini G; Lucacchini A
J Med Chem; 1992 Jun; 35(12):2214-20. PubMed ID: 1319492
[TBL] [Abstract][Full Text] [Related]
20. Gut bacteria provide precursors of benzodiazepine receptor ligands in a rat model of hepatic encephalopathy.
Yurdaydin C; Walsh TJ; Engler HD; Ha JH; Li Y; Jones EA; Basile AS
Brain Res; 1995 May; 679(1):42-8. PubMed ID: 7648264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
